Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards - Vaccine development holds the greatest promise and the greatest challenge for protecting the worldwide population from an

ADVERTISEMENT

Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards
Vaccine development holds the greatest promise and the greatest challenge for protecting the worldwide population from an avian flu pandemic


BioPharm International
Volume 19, Issue 2

8. Slater (2004), "Industry and Government Perspective in Influenza Control," Texas Heart Inst. J. 31:42-44.

9. Coyle (2005), "Consumer Groups Slam Vaccine Bill," National Law Journal Dec. 13, 2005.

10. Trivalent influenza vaccines were added to the VICP in July 2005, see http://www.hrsa.gov/osp/vicp/

11. See Coyle (2005), supra.

12. Section 6 of S. 1878, the Biodefense and Pandemic Vaccine and Drug Development Act of 2005.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Novartis Sells Influenza Vaccine Business to CSL for $275 Million
October 27, 2014
Author Guidelines
Source: BioPharm International,
Click here